Biblio Discovery — Demo Discovery Service

4 results for "Saiming Cheng"

Showing 1–4 · 0.54 seconds · RSS

  1. Journal Article

    Evaluation of pregnancy outcomes using a novel hysterosalpingography scoring system for tubal patency

    Huijun Yang; Yali Xu; Saiming Cheng et al.

    European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol. 29 · 2026 · English · DOAJ Scopus

    Objective: This study aims to evaluate pregnancy rates using a novel classification system based on hysterosalpingography (HSG) findings, categorizing tubal patency as either patent or functionally deficient. Furthermore, the study assesses the predictive value of this scoring system for fertility…

  2. Journal Article

    Clinical investigation of fertility after uterine artery embolization combined with dilation and curettage(D&C) or D&C alone for cesarean scar pregnancies

    Jie Gao; Wenjing Wang; Zhuoying Zhang et al.

    European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol. 26 · 2025 · English · DOAJ Scopus

    Objective: The aim of this study was to compare the reproductive outcomes of patients with cesarean scar pregnancies (CSP) following uterine artery embolization (UAE) and dilation and curettage (D&C) treatments, and to evaluate the impact of UAE on fertility. Materials: and methods: A retrospective…

  3. Journal Article

    The value of MRI in differentiating ovarian clear cell carcinoma from other adnexal masses with O-RADS MRI scores of 4–5

    Lingling Lin; Le Fu; Huawei Wu et al.

    Insights into Imaging, Vol. 16 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Objective To assess the utility of clinical and MRI features in distinguishing ovarian clear cell carcinoma (CCC) from adnexal masses with ovarian-adnexal reporting and data system (O-RADS) MRI scores of 4–5. Methods This retrospective study included 850 patients with indeterminate adnexal…

  4. Journal Article

    MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease

    Jing Feng; Qi Feng; Yueying Chen et al.

    Frontiers in Nutrition, Vol. 8 · 2022 · English · DOAJ Scopus

    Up to 50% of patients with Crohn's disease (CD) experience secondary loss of response (SLR) to infliximab. Patients with SLR may show clinical signs of iron deficiency as a result of inflammation despite being iron-replete. The magnetic resonance imaging (MRI)-based radiomic index, R2*, can detect…